A new UC San Diego analysis of 21,189 adults aged 65+ found 11.4% of past-year cannabis users met DSM-5 criteria for cannabis use disorder, with most cases mild.

A University of Georgia analysis of 20M+ responses finds a 7% drop in health-related absences where medical cannabis is accessible, with strongest effects in physical jobs.

A Brazilian team reported caregiver-rated improvements after individualized full-spectrum cannabis extracts in 20 ASD patients, with small-sample limits and no control group.

NORML reports a pediatric clinical trial found a plant-derived cannabis preparation was safe and effective for autism, with disease severity falling about 2 points on a 7‑point scale after eight weeks.